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Preeclampsia is a hypertensive and inflammatory pregnancy disorder associated with
cholesterol accumulation and inflammation at the maternal-fetal interface. Preeclampsia
can be complicated with fetal growth restriction (FGR) and shares risk factors
and pathophysiological mechanisms with cardiovascular disease. Cholesterol crystal
mediated NLRP3 inflammasome activation is central to cardiovascular disease and
the pathway has been implicated in placental inflammation in preeclampsia. Direct
maternal-fetal interaction occurs both in the uterine wall decidua and at the
placental surface and these aligned sites constitute the maternal-fetal interface.
This study aimed to investigate cholesterol crystal accumulation and NLRP3
inflammasome expression by maternal and fetal cells in the uterine wall decidua of
normal and preeclamptic pregnancies. Pregnant women with normal (n = 43) and
preeclamptic pregnancies with (n = 28) and without (n = 19) FGR were included
at delivery. Cholesterol crystals were imaged in decidual tissue by both second
harmonic generation microscopy and polarization filter reflected light microscopy.
Quantitative expression analysis of NLRP3, IL-1β and cell markers was performed
by immunohistochemistry and automated image processing. Functional NLRP3
activation was assessed in cultured decidual explants. Cholesterol crystals were
identified in decidual tissue, both in the tissue stroma and near uterine vessels.
The cholesterol crystals in decidua varied between pregnancies in distribution and
cluster size. Decidual expression of the inflammasome components NLRP3 and IL-1β
was located to fetal trophoblasts and maternal leukocytes and was strongest in
areas of proximity between these cell types. Pathway functionality was confirmed
by cholesterol crystal activation of IL-1β in cultured decidual explants. Preeclampsia
without FGR was associated with increased trophoblast dependent NLRP3 and IL-1β
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expression, particularly in the decidual areas of trophoblast and leukocyte proximity.
Our findings suggest that decidual accumulation of cholesterol crystals may activate the
NLRP3 inflammasome and contribute to decidual inflammation and that this pathway is
strengthened in areas with close maternal-fetal interaction in preeclampsia without FGR.
Keywords: cholesterol crystals, decidua, fetal growth restriction, NLRP3 inflammasome, inflammation, IL-1β,
placenta, preeclampsia
INTRODUCTION
Pregnancy is characterized by low-grade inflammation at the
maternal-fetal interface and systemically in the mother, and
this is aggravated to harmful levels in the pregnancy disorder
preeclampsia (1). Preeclampsia is clinically characterized in
the second half of pregnancy by new onset hypertension and
proteinuria or maternal organ dysfunction and/or uteroplacental
dysfunction (2, 3). The disease occurs in 4–5% of pregnancies
and is a leading cause of maternal and fetal morbidity and
mortality, often complicating with fetal growth restriction
(FGR) (4). Preeclampsia is considered a warning sign for
cardiovascular disease (CVD) later in life and common
pathophysiological mechanisms are shared (5, 6). Cholesterol
mediated inflammation has been suggested as a link between the
disorders, a theory supported by preeclamptic pregnancies being
characterized by a pro-atherogenic maternal lipid profile and
cholesterol accumulation at the maternal-fetal interface (7, 8).
The uterine wall decidua and the placenta are the two
aligned sites for direct maternal-fetal immunological interaction
throughout pregnancy. In the decidua, specialized fetal cells,
called extravillous trophoblasts, invade the tissue and establish
a direct molecular dialogue with resident maternal cells such as
decidual stromal cells and maternal immune cells (9). Leukocytes
are key cells in modulating trophoblast behavior (10). Placental
cytotrophoblasts fuse together to form a multinucleated cell
layer, the syncytiotrophoblast, that covers the placenta and
directly interacts with maternal blood. Preeclampsia and FGR
are associated with reduced trophoblast invasion and impaired
artery remodeling in the uterine wall, leading to placental
oxidative stress and inflammation that increase as the fetus
grows (11–13). Although significant progress has been made
in understanding the central role of placental inflammation
for development of preeclampsia and FGR (13–15), little is
known about the involvement of inflammatory mechanisms in
the decidua.
Intracellular crystallization of cholesterol is a complex
process that occurs upon endocytosis of oxidized low-density
lipoprotein (oxLDL) and this process has been extensively
studied in the arterial wall in atherosclerosis (16, 17). The
cholesterol crystals promote the development of atherosclerotic
lesions by activation of the potent Nod-like receptor protein
(NLRP)3 inflammasome (18). The resulting interleukin (IL)-1β
production from this powerful activation may lead to extensive
inflammation and tissue damage (15, 19). Trophoblasts express
receptors that enable cholesterol transport and uptake of
oxLDL has been shown to reduce trophoblast invasiveness
(20–23), but cholesterol crystals have not been investigated
at the maternal-fetal interface. Dysregulated lipid transport
by reduced expression of ATP-binding cassette transporter
(ABCA1) has been associated with cholesterol accumulation
at the placental syncytiotrophoblast layer in preeclampsia (24)
and in primary extravillous trophoblasts (25). Preeclampsia
is associated with increased maternal systemic inflammatory
markers including total cholesterol, oxLDL, IL-1β and soluble
fms-like tyrosine kinase-1 (sFlt-1) (26–28). The NLRP3
inflammasome pathway in preeclampsia has been recently
reviewed and mechanistically illustrated (29). We have
previously shown that the NLRP3 inflammasome is active
in the placenta and associated with preeclampsia, with a
central involvement of trophoblasts (28). In the decidua,
increased cholesterol accumulation in preeclampsia (7) and
NLRP3 inflammasome expression in cultured cells (30) has
been shown. This indicates a role for cholesterol crystal
mediated NLRP3 inflammasome activation across the maternal-
fetal interface, but the decidual involvement still needs to
be determined.
We hypothesize that cholesterol accumulation in the decidua
results in formation of cholesterol crystals, which induce
decidual NLRP3 inflammasome activation and influence the
important dialogue between trophoblasts and maternal immune
cells. This study aimed to characterize cholesterol crystal
accumulation and NLRP3 inflammasome expression bymaternal
and fetal cells in the uterine wall decidua of normal and
preeclamptic pregnancies.
METHODS
Study Participants and Decidual Biopsies
Women with normal and preeclamptic pregnancies with and
without FGR were recruited at St. Olavs and Haukeland
University Hospitals during 2002-2012. Preeclampsia was
defined as persistent hypertension exceeding 140/90 mmHg plus
proteinuria ≥0.3 g/24 h or ≥+1 by dipstick after 20 weeks of
gestation. FGRwas diagnosed by serial ultrasoundmeasurements
showing reduced intrauterine growth (n = 27), or, for neonates
small for gestational age (n = 1), birth weight <5th percentile
of Norwegian reference curves (31) combined with clinically
and sonographically suspected FGR and/or postpartum defined
placental pathology. Only singleton pregnancies undergoing
cesarean section with no signs of labor were included. Decidua
basalis tissue was collected by vacuum suction of the placental
bed during cesarean section (7, 32). Tissue samples were either
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fixed in 10% neutral-buffered formalin and embedded in paraffin
or snap frozen and stored at−80◦C.
Placentas were collected from normal pregnancies after
delivery by elective cesarean section for immediate isolation of
decidual explants. The decidual tissue was dissected from the
central region of the maternal side of the placenta. Samples were
processed and cultured within 1.5 h after delivery.
Decidual Explants
Decidual tissue was washed in sterile phosphate-buffered saline,
cut into pieces (explants with wet weight range of 15–
33mg) and distributed in the culture plate evenly between
the different culture conditions (24 ± 2mg, mean ± standard
deviation). There were no significant differences in explant
weight between the culture conditions. Explants were cultured in
FIGURE 1 | Cholesterol crystals in decidual tissue. (A) Decidual tissue imaged by second harmonic generation microscopy. The arrow heads indicate cholesterol
crystals and the arrow points to collagen fibers in the vessel wall. (B,C) Decidual tissue stained by DAPI and imaged by polarized light microscopy. Nuclei (blue) and
cholesterol crystals (green) are shown near a vessel wall (B) and within tissue stroma (C). (D–G) Representative images obtained by polarized light microscopy for
cholesterol crystal quantification. (D) Unprocessed image of cholesterol crystals (green). The same image processed by MATLAB showing (E) total cholesterol crystals
and separated into (F) large and (G) small clusters of cholesterol crystals. Scale bar 100 µM.
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Ham’s F12/Dulbecco’s modified Eagle’s medium (DMEM) with
10% fetal bovine serum and 100 mg/mL penicillin-streptomycin
(Sigma-Aldrich) and incubated for 24 h at 37◦C, 8% O2 and
5% CO2 (33). Culture medium was then replaced by fresh
culture medium with or without 500 pg/ml LPS priming
(#tlrl-3pelps, InvivoGen, California, United States). After 2 h,
the medium was replaced by fresh culture medium with or
without stimuli; 200 or 2,000µg/ml synthetic cholesterol crystals
(#C3045, Sigma-Aldrich) or the positive control 3mM ATP
(#A7699, Sigma-Aldrich). Supernatants were collected after 24 h,
centrifuged and stored at −80◦C. Six technical replicates for
each experimental condition were combined before analysis.
Tissue viability was assessed by lactate dehydrogenase (LDH)
cytotoxicity assay (#04744926001, Roche, Basel, Switzerland)
(Supplementary Figure 1). IL-1β levels in supernatants were
measured undiluted in duplicate using quantitative sandwich
ELISA (#557953, BD Biosciences, New Jersey, United States).
Cholesterol Crystal Imaging and
Automated Quantification
To preserve cholesterol crystals, the decidual cryosections (5µm)
were analyzed untreated. DAPI mounting medium (#F6057,
Sigma-Aldrich, Missouri, United States) was used to identify
cellular nuclei. Cholesterol crystals in the decidual cryosections
were first assessed by second harmonic generation microscopy
(25X magnification Leica SP8 confocal microscope, Wetzlar;
Germany). For further analysis of cholesterol crystals, three
adjacent TIFF images (2,080 × 1,544 pixels) were obtained
from three different regions in the decidual section using
polarization filter reflected light microscopy (20X magnification,
Inverted fluorescence microscope Olympus IX71, Tokyo, Japan)
and defined microscope settings. The cholesterol crystals in
the nine TIFF images per decidua were quantified by a
customized MATLAB script (version 2018a, the MathWorks
Inc., Massachusetts, United States) developed for automatic
quantification of positive pixels. The total cholesterol crystal
positive pixels in each decidua was determined by the sum of
the positive pixels quantified in the nine pictures. The number
of positive pixels in each of the nine images was used to assess
the variation in cholesterol crystal tissue distribution within each
decidua. To evaluate the size of the observed cholesterol crystals,
aggregation of positive pixels was determined by defining small
(<50 pixels) and large (≥50 pixels) cholesterol crystal clusters
(representative image in Figures 1D–G). To verify that the
crystals dissolved in alcohol, two serial decidual cryosections
(5µm) were obtained from four decidual tissue samples. One
slide from each decidual sample was treated with PBS and the
other slide was immersed in alcohol at room temperature for 60 s.
Immunohistochemical Staining
Immunohistochemistry staining was performed in paraffin
embedded decidua. Serial sections of 3µm were pre-treated
in PT link (#PT101, Dako, Glostrup, Denmark) using Target
Retrieval Solution (#K8005 or #K8004, Dako) at 97◦C for
20min, and all sections were treated with peroxidase blocking
solution (#K4007, Dako) or with dual peroxidase and alkaline
phosphatase blocking solution (#K5361, Dako). Decidual tissue
sections were incubated overnight at 4◦C with antibodies
against NLRP3 (1:100, #AG-20B-0014-C100, AdipoGen,
California, United States) or IL-1β (1:200, #NB600-633, Novus,
Colorado, United States); or for 45min with cytokeratin 7
(CK7) (1:300, #M0851, Dako) or 40min with CD45 (1:150,
#M0701, Dako) at room temperature. All sections were
incubated for 30min with HRP-labeled polymer (#K4007, Dako)
and for 10min with DAB+ as chromogen (1:50, #K4007 or
K5361, Dako). Decidual CK7 sections were double stained
with smooth muscle actin (SMA) antibodies (1:300, #M0851,
Dako) using EnVision G|2 Doublestain System Rabbit/Mouse
(DAB+/Permanent Red) Kit system (K#5361, Dako). Overnight
staining was performed manually and otherwise by Autostainer
Plus (#S3800, Dako). Sections were counterstained with
hematoxylin. Negative isotype controls were included
(Figures 3G,H). In addition to the immunohistochemical
staining, a routine staining with hematoxylin (#75290, Chemi-
Teknik AS, Oslo, Norway), erythrosine 239 (#720-0179, VWR,
Pennsylvania, United States) and saffron (#75100, Chemi-
Teknik AS) (HES) was performed for each decidua using
a Sakura Tissue-Tek © Prisma StainerTM (Sakura Finetek,
Oslo, Norway).
Automated Quantification of Protein
Expression
Decidual tissue slides were scanned with the EVOSTM FL
Auto Imaging System (Thermo Fisher Scientific, Massachusetts,
United States), using 20X magnification and defined microscope
settings. The large decidual scans varied in size depending
on available tissue and consisted of 4 to 81 bright field TIFF
images (2,048 × 1,536 pixels) per sample slide. A customized
ImageJ (ImageJ2) (34, 35) script was used to perform background
correction (Image calculator: Difference (img1 = |img1–img2|)
and tile stitching [Grid/Collection stitching plugin (36)]. Smooth
muscle tissue, placental tissue, blood vessels and tissue with
poor morphology were excluded by manually defining regions
of disinterest. NLRP3 and IL-1β expression was automatically
quantified in the large tissue section scan for each decidua
by a customized MATLAB script, and the protein expression
quantified with examiners blinded to pregnancy outcomes. Cell
specific staining was used to select decidual regions containing
trophoblasts (CK7+) and leukocytes (CD45+). A mask of
patches (1,325 × 1,325µm) defining trophoblasts, maternal
leukocytes, andmaternal tissue without trophoblasts, was created
for each decidual sample by using serial tissue section scans
of cell-specific stained trophoblasts (CK7+) and leukocytes
(CD45+). These masks were used to relate NLRP3 and IL-
1β expression levels to trophoblasts and maternal leukocytes in
the spatially aligned NLRP3 and IL-1β images. The expression
density of CK7, CD45, NLRP3, and IL-1β in decidual tissue was
calculated as the total number of positive stained pixels divided
by the total amount of tissue pixels analyzed, to account for
varying amounts of tissue between the samples. The expression
intensity of NLRP3 and IL-1β were calculated as average staining
intensity of all patches using a color deconvolution algorithm
based on DAB specific RGB absorption (37).
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Statistical Methods
Statistical analyses were performed in SPSS (IBM SPSS Statistics
26, Illinois, United States) and GraphPad Prism (Prism8,
California, United States). For clinical data, one-way ANOVA or
Kruskal-Wallis with Tukey’s or Dunn’s multiple comparison post
hoc test, respectively, were used for comparisons of continuous
variables, and Fisher’s exact test for categorical variables. Protein
measurements in supernatants were analyzed by Kruskal-Wallis
with Dunn’s multiple comparison post-hoc test.
NLRP3 and IL-1β expression levels were compared between
study groups using a linear mixed model with recruitment
location, study group and the trophoblast and leukocyte densities
implemented as fixed effects. Subject combinations and intercept
were included as random effects. The cholesterol crystal analysis
was performed by a linear mixed model with recruitment
location and study group as fixed effect. Correlation between
variables was performed by calculating Pearson’s correlation
coefficient. Alpha level was set to 0.05.
RESULTS
Study Material
A total of 90 women with normal (n = 43) and preeclamptic
pregnancies with (n = 28) and without FGR (n = 19) were
included to the study (Table 1). The preeclamptic pregnancies
with and without FGR, included more primiparas, had higher
systolic and diastolic blood pressure, and their infants were
delivered at earlier gestation with lower placental and birth
weights, compared to normal pregnancies. The gestational age
at delivery, as well as placenta and birth weights, were lower in
preeclamptic pregnancies complicated with FGR compared to
preeclamptic pregnancies without FGR (Table 1).
For the three pregnancies included in the decidual explant
analysis, maternal age ranged between 31 and 38 years and
gestational age between 38 and 39 weeks.
Cholesterol Crystals
Decidual cryosections from 76 women with normal (n = 34)
and preeclamptic pregnancies with (n = 27) and without FGR
(n = 15) were included. A marked presence of cholesterol
crystals was observed dispersed in decidual tissue by both second
harmonic generation (Figure 1A) and polarized light microscopy
(Figures 1B–D). The crystals appeared to be localized both intra
and extracellularly and cells containing cholesterol crystals were
observed close to uterine vessels (Figure 1B) and within the
tissue stroma (Figure 1C). The cholesterol crystals were not
uniformly dispersed within the tissue stroma but were instead
aggregated in distinct areas of the tissue and the distribution of
such cholesterol crystal areas varied markedly between different
pregnancies (Figure 2A). The cholesterol crystals appeared
in the decidua as clusters of different size, and the ratio
between large and small clusters in normal pregnancies was
about 2:3 (Figure 2B). The cholesterol crystals detected in the
decidua dissolved after alcohol treatment for 60 s, as expected
(Supplementary Figure 2).
No significant differences in the amount, distribution and
cluster size of decidual cholesterol crystals were detected between
TABLE 1 | Clinical characteristics of subjects included in third trimester decidual












Maternal age, years 31.2 (± 5.4)* 29.3 (± 4,9) 29.5 (± 5.3)
Primiparas, n (%) 7 (16) 12 (63)*|| 17 (61)*||
BMI† 24.8 (± 3.9) 25.7 (± 4.6) 25.4 (± 4.1)
Characteristics at time
of delivery
Systolic BP, mmHg‡ 119 (± 10) 153 (± 20)|| 148 (±18)||
Diastolic BP, mmHg‡ 72 (± 8) 100 (± 12)|| 96 (± 11)||
Severe preeclampsia, n (%) n.a. 17 (89) 20 (69)
Early onset preeclampsia
<34 weeks, n (%)
n.a. 15 (79) 21 (79)
Placental weight, g§ 638 (102) 475 (128)|| 290 (101)||#
Fetal birth weight, g 3,409 (332) 2,224 (583)|| 1,311 (469)||#
Fetal sex, female, n (%) 23 (53.5) 8 (42.1) 16 (60.7)
Gestational age, weeks 38.6 (0.6) 33.6 (2.7)|| 31.3 (3.1)||#
FGR, fetal growth restriction; BMI, body mass index; BP, blood pressure; n.a.,
not applicable.
Continuous variables listed as means (± standard deviation) or median (interquartile
range), assessed for differences between groups by one-way ANOVA with Tukey’s post
hoc test or Kruskal-Wallis with Dunn’s post hoc test. Categorical variables listed as number
(percent in column), assessed for differences between groups by Fisher’s exact test.
*Information missing from one woman.
†
Maternal BMI in first trimester. Information is missing from five women.
‡
Blood pressure from last healthcare visit before delivery. Information missing from
one woman.
§ Information missing from 12 women.
||P < 0.05 vs. normal pregnancies.
#P < 0.05 vs. preeclampsia without FGR.
normal pregnancies and preeclamptic pregnancies with or
without FGR (Figure 2C and data not shown).
Decidual Tissue Composition
Morphological assessment of cells and structures in the uterine
wall decidua showed presence of fetal trophoblasts (CK7+),
maternal leukocytes (CD45+), decidual stroma cells and
uterine blood vessels (CD31+ endothelium) (Figures 3A–D).
Trophoblasts were observed isolated or clustered in the tissue
and were either apart from or in close contact with maternal
leukocytes and decidual stroma cells. Both mononucleated
trophoblasts and multinucleated trophoblast giant cells were
identified and included in the analysis.
Decidual NLRP3 Inflammasome
Expression and Function
Paraffin embedded decidual tissue sections from 85 women
with normal (n = 41) and preeclamptic pregnancies with
(n = 26) and without FGR (n = 18) were included. From
these, two pregnancies were excluded from the IL-1β and four
from the NLRP3 expression analysis due to methodological
errors in immunostaining or image processing. NLRP3
was strongly expressed in the cytoplasm of cells in the
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FIGURE 2 | Quantification of cholesterol crystal in decidual tissue. Cholesterol crystal (CC) quantification was performed in nine pictures per decidual cryosection
(5µm). (A) Descriptive statistics of the cholesterol crystal positive pixels, shown as estimated means with standard error of mean, per normal pregnancy. (B)
Percentages of the total cholesterol crystal positive pixels corresponding to small CC clusters (<50 pixels) and large CC clusters (≥50 pixels), in normal pregnancies.
(C) Total cholesterol crystal positive pixels were quantified in decidual cryosections obtained from normal (n = 34) and preeclamptic pregnancies with (n = 27) and
without fetal growth restriction (FGR) (n = 15).
decidual tissue, including trophoblasts, maternal leukocytes,
decidual stromal cells and endothelial cells (Figure 3E).
The cell specific expression pattern of IL-1β in decidua was
comparable to NLRP3 (Figure 3F). The cellular distribution
and overall expression of NLRP3 and IL-1β in decidua of
preeclamptic pregnancies appeared comparable to normal
pregnancies (Supplementary Figure 3). The expression
intensity (Figure 4, Supplementary Table 1) and density
(Supplementary Table 2) of decidual NLRP3 and IL-1β were
quantified. Preeclamptic pregnancies with normal fetal growth
showed higher decidual expression intensity (Figures 4A,B)
and density (Supplementary Table 2) of both NLRP3 and
IL-1β compared to normal pregnancies (NLRP3 intensity P =
0.028 and density P = 0.006; IL-1β intensity P = 0.044, and
density P = 0.010) and preeclamptic pregnancies complicated
with FGR (NLRP3 intensity P = 0.372 and density P =
0.057; IL-1β intensity P = 0.024 and density P = 0.065,
respectively). The increased decidual NLRP3 and IL-1β
expression associated with preeclampsia with normal fetal
growth could not be explained by differences in decidual
leukocyte and trophoblast density (Supplementary Table 2).
Preeclamptic pregnancies with FGR were associated with higher
density of leukocytes, but not trophoblasts, compared to both
preeclampsia with normal fetal growth and normal pregnancies
(Supplementary Table 2).
A significant positive correlation between the decidual
expression intensity of NLRP3 and IL-1βwas observed in normal
pregnancies (R = 0.516, P = 0.01) and pregnancies complicated
with preeclampsia without FGR (R= 0.499, P = 0.05), but not in
preeclamptic pregnancies with FGR (R = 0.323, P = 0.116). We
have previously reported placental NLRP3 and IL-1β expression
in 21 of the pregnancies included in this study (28). In this
subgroup, we found no correlation between the decidual and
placental expression intensity, neither in preeclampsia with (n =
5, NLRP3 R = −0.329, P = 0.588; IL-1β R = −0.579, P = 0.306)
or without FGR (n= 10, NLRP3 R= 0.096, P= 0.791; IL-1β R=
−0.251, P = 0.484), nor in normal pregnancies (n= 6, NLRP3 R
=−0.718, P = 0.108; IL-1β R=−0.059, P = 0.912).
Synthetic cholesterol crystals induced NLRP3 inflammasome
activation in LPS primed decidual tissue explants (n = 3)
from normal pregnancies by significantly increasing the
release of IL-1β (Figure 5). LDH cytotoxicity assay confirmed
that the stimuli had no toxic effect on tissue viability
(Supplementary Figure 1).
Cellular NLRP3 Inflammasome Expression
in Decidua
A significant positive correlation was found between the density
of trophoblasts and the expression intensity of both NLRP3
(R = 0.244, P = 0.01) and IL-1β (R = 0.289, P = 0.01)
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FIGURE 3 | Immunohistochemical staining of decidua from a normal
pregnancy. Representative images of decidual tissue from a normal pregnancy
at gestational age 40 weeks. (A) HES; (B) the trophoblast marker cytokeratin 7
(CK7); (C) the endothelium marker CD31; (D) the leukocyte marker CD45; (E)
nod-like receptor protein (NLRP)3; and (F) interleukin (IL)-1β. Negative isotype
control shown for (G) NLRP3; and (H) IL-1β. Black arrowheads indicate
trophoblasts, black arrows indicate maternal decidual stroma cells, dashed
arrows indicate maternal leukocytes and transparent arrowhead indicate
endothelial cells. Scale bar 200µM.
in decidua. In decidual areas containing trophoblasts, both
the NLRP3 and IL-1β expression intensity was significantly
higher in preeclamptic pregnancies with normal fetal growth
compared to normal pregnancies (NLRP3 P = 0.019; IL-1β P =
0.023) (Figures 4C,D). Further, the IL-1β expression intensity in
trophoblast-containing decidual areas was significantly higher in
preeclampsia without FGR compared to preeclampsia with FGR
(P = 0.021) (Figure 4D). Excluding trophoblasts from analysis
abolished the significant differences between the study groups
(Supplementary Table 1).
The maternal leukocyte density in the decidua correlated
weakly with the decidual expression intensity of NLRP3 (R =
0.044, P = 0.01) and IL-1β (R = 0.040, P = 0.01). Decidual
tissue containing leukocytes showed higher expression intensity
of NLRP3, but not IL-1β, in preeclamptic pregnancies with
normal fetal growth compared to normal pregnancies (NLRP3
P = 0.025 and IL-1β P = 0.052) (Supplementary Table 1).
A closer look at decidual tissue with trophoblast and maternal
leukocytes in proximity showed that the expression intensity of
NLRP3 and IL-1β was significantly increased in preeclampsia
without FGR compared to normal pregnancies (NLRP3 P =
0.017 and IL-1β P = 0.031) (Figures 4E,F). A comparison
between trophoblast containing areas was made to assess the
influence of leukocyte presence (Figure 6). Significantly higher
expression intensity of both NLRP3 and IL-1β expression
was observed in areas containing trophoblast and maternal
leukocytes in proximity, compared to areas with trophoblasts
and no leukocytes, and this dependence on maternal-fetal cell
proximity was apparent in all study groups (Figure 6).
DISCUSSION
This study is the first to reveal the presence of cholesterol
crystals at the maternal-fetal interface in the uterine wall decidua,
and the crystals were shown to be markedly present in both
normal and preeclamptic pregnancies. The cholesterol crystal
responsive NLRP3 inflammasome and IL-1β were expressed by
both fetal trophoblasts and maternal leukocytes in the decidua.
Pathway functionality was confirmed by cholesterol crystal
mediated activation of IL-1β production in decidual explants.
The expression intensity levels of NLRP3 and IL-1β correlated
within the decidua but not between the two sites of the maternal-
fetal interface; decidua and placenta. Preeclampsia with normal
fetal growth was associated with increased expression of NLRP3
and IL-1β, particularly in decidual areas of close maternal-
fetal interaction.
Normal pregnancy is characterized by elevated maternal
serum cholesterol and uric acid levels (7, 28, 38), and the
correlation with increased serum levels of C-reactive protein
(CRP) and sFlt-1 (28) indicates a potential contribution to the
elevated maternal inflammatory state of normal pregnancies.
The increased serum cholesterol may contribute to accumulation
of cholesterol at the maternal-fetal interface (7), eventually
leading to formation of cholesterol crystals in decidual tissue, as
shown in the present study. Both trophoblasts and leukocytes
are equipped with receptors that enable cholesterol uptake,
such as the scavenger receptor CD36 (16, 21, 22, 39). Another
aspect of how cholesterol crystals may contribute to decidual
inflammation is linked to atherosis formation in uterine arteries,
a vascular malformation resembling early stage atherosclerosis
(40). CD36 is involved in macrophage foam cell formation
and atherosclerosis progression by mediating endocytosis and
conversion of oxLDL into cholesterol crystals, thus promoting
complement and NLRP3 inflammasome activation (16, 41–
43). Oxidative stress in the decidua may induce accumulation
of oxLDL and cholesterol crystal formation. A similar role
for cholesterol crystals in decidual macrophage foam cell
accumulation and atherosis formation is supported by our
observation of cholesterol crystals around the wall of uterine
vessels, but further investigation is needed. We found that
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FIGURE 4 | Expression intensity levels of nod-like receptor protein (NLRP)3 and interleukin (IL)-1β in decidual tissue. (A,C,E) NLRP3 expression intensity in decidual
tissue from normal (n = 39) and preeclamptic pregnancies with (n = 26) and without fetal growth restriction (FGR) (n = 16); and (B,D,F) IL-1β expression intensity in
normal (n = 40) and preeclamptic pregnancies with (n = 25) and without FGR (n = 18). Expression intensity is shown for (A,B) decidual tissue; (C,D) decidual areas
containing trophoblasts; and (E,F) decidual areas containing trophoblast and leukocytes. Data were analyzed by a linear mixed model and expression levels are
shown as estimated means with standard error of mean. *P < 0.05. A.U. indicates arbitrary units.
cells containing cholesterol crystals appeared aggregated within
decidual tissue, rather than randomly scattered, suggesting that
cholesterol crystal mediated inflammation may be localized to
specific regions in the decidua. Previous studies have suggested
that the size of cholesterol crystals and their clusters may
be an important factor in the inflammatory potential (44,
45), but this hypothesis was not substantiated for decidual
inflammation in the current study. The amount and size of
cholesterol crystals in the decidua did not differ between
normal and preeclamptic pregnancies. Further assessment of cell
specific involvement in the decidual uptake and formation of
cholesterol crystals, as well as involvement of relevant priming
signals, such as complement factors (46), is warranted to fully
understand the inflammatory potential of cholesterol crystals
at the maternal-fetal interface. It must also be determined
how different pathological processes in decidua interact since
oxidative stress may promote the accumulation of oxLDL and
cholesterol crystal formation (16, 17). The use of established
advanced microscopy methodology for cholesterol imaging
learned from atherosclerosis and hepatocytes lipid droplets (47–
49), combined with removal of the crystals by alcohol treatment
(50), strongly support that the imaged crystals in decidua are
crystalline cholesterol. Still, further verification of the chemical
identity of the crystals may be performed by other advanced
microscopy techniques, such as coherent anti-Stokes Raman
scattering (CARS) imaging.
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FIGURE 5 | Interleukin (IL)-1β response following cholesterol crystal
stimulation of decidual explants. Decidual explants from normal pregnancies (n
= 3) were primed for 2 h with or without lipopolysaccharide (LPS), before
adding cholesterol crystals (CC, 200 or 2,000µg/ml) or adenosine
triphosphate (ATP) for 24 h. Six technical replicates were included for each
experimental condition. Release of IL-1β to the supernatant was measured by
ELISA and presented as mean with standard error of mean, relative to explant
weight. Data were analyzed using Kruskal-Wallis test with Dunn’s multiple
comparison post-hoc test. *P < 0.05. PBS, phosphate-buffered saline.
This is the first demonstration of NLRP3 and IL-1β protein
expression in maternal and fetal cells in the uterine wall
decidua. A report of gene expression of NLRP3 inflammasome
components in isolated first trimester decidual stromal
cells partly supports our findings (30). Combined with our
previous discovery of NLRP3 and IL-1β expression in placental
trophoblasts of early and late pregnancies (28), this study clearly
supports a role for NLRP3 inflammasome activation at both
sites of the maternal-fetal interface throughout pregnancy. In
addition, the positive correlation between decidual expression
of NLRP3 and the responsive cytokine IL-1β substantiates
the functionality of the NLRP3 inflammasome in decidua.
Extravillous trophoblasts were here shown to be central for
the decidual NLRP3 inflammasome response. This means that
the characterization of placental trophoblasts and trophoblast
cell lines as immunocompetent cells by their functional pattern
recognition receptors (PRR) by us (28, 51, 52) and others
(9, 53), has now been extended to extravillous trophoblasts in
the decidua. This indicates importance for immunomodulating
trophoblast activity at the maternal side of the maternal-fetal
interface in the final stages of pregnancy, with dependence on
the proximity and possible direct interaction between fetal and
maternal cells. Supporting such maternal-fetal communication
is that maternal leukocytes and trophoblasts in the decidua
express complementary ligands and receptors (9, 10) and that
leukocytes are key cells in modulating trophoblast behavior (54).
In addition to leukocytes and trophoblasts, decidual stromal cells
markedly expressed NLRP3 and IL-1β and are considered
potential responders to cholesterol crystals, but further
studies focused on this cell type are needed to address their
inflammatory role.
Preeclampsia without FGR was associated with increased
decidual expression of NLRP3 and IL-1β, suggesting that the
NLRP3 inflammasome aggravates the inflammatory response
and substantiates the reported shift to a pro-inflammatory
profile and cell type distribution at the maternal-fetal interface in
preeclampsia (9, 14, 29). The increased decidual inflammasome
expression was trophoblast dependent and strongest in areas
where trophoblast and leukocytes are in proximity, suggesting
that NLRP3 mediated inflammation may disturb maternal-fetal
communication. The novel identification of decidual cholesterol
crystals combined with increased NLRP3 inflammasome
expression presents a novel link between the pathophysiology
of CVD and preeclampsia. NLRP3 inflammasome response may
lead to extensive tissue damage and cell death and is associated
with formation and progression of atherosclerotic lesions
(18, 19). Correspondingly, increased formation of decidual
atherosis and inflammation at the maternal-fetal interface
are pathophysiological features of preeclampsia (40, 55). The
NLRP3 inflammasome expression pattern in decidua further
points to interesting pathophysiological differences between
preeclampsia subgroups. We have previously demonstrated a
placental role for the NLRP3 inflammasome in preeclampsia
combined with FGR (28), while the decidual contribution
presented here was apparent in preeclampsia without FGR.
This points to divergent NLRP3 inflammasome activation in
preeclampsia subgroups. Supporting such divergent regulation is
the lack of correlation between decidual and placental expression
levels of NLRP3 and IL-1β, indicating that activators in the
maternal serum affect placental and decidual tissue differentially
and that the local inflammatory responses in the decidua and
placenta are not directly coordinated. We hypothesize that the
placental tissue may be more influenced by placental dysfunction
and fetal complications. FGR has been shown associated to
a fetal pro-atherogenic lipid profile and placental cholesterol
accumulation due to abnormal cholesterol transport (24, 56).
This may lead to cholesterol accumulation and crystallization
in the placenta and activation of the NLRP3 inflammasome
in a process that may not influence decidual tissue. In the
present study, increased decidual NLRP3 inflammasome
response was observed in preeclampsia without FGR, and
this could indicate that the decidual tissue may respond
more to the increased maternal danger signals, including
pro-atherogenic lipid profile, circulating levels of inflammatory
mediators, such as HMGB1 and uric acid, and predisposition
to inflammation.
Therapeutic and preventive approaches in preeclampsia are
limited. A large prospective study showed limited preventive
effect of administration of low-dose anti-inflammatory and
antiplatelet agent aspirin on preeclampsia development (57).
Pravastatin, used for treatment of dyslipidemia and prevention
of CVD, is a suggested candidate for treatment and prevention of
preeclampsia (58). In addition to reducing hypercholesterolemia,
statins may ameliorate major pathological responses involved in
preeclampsia, including inhibition of sFlt-1 release and reduction
of inflammation and oxidative stress (59). Importantly, statins
may inhibit formation and improve solubility of cholesterol
crystals in atherosclerotic plaques (60), adding to the beneficial
effects of these cholesterol-lowering drugs. Further investigation
is needed to demonstrate whether a positive effect of pravastatin
in preeclampsia may involve removal of cholesterol crystals at the
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FIGURE 6 | Expression intensity levels of nod-like receptor protein (NLRP)3 and interleukin (IL)-1β in decidual tissue related to presence of trophoblast and leukocytes.
NLRP3 (A,C,E) and IL-1β (B,D,F) expression was measured in normal pregnancies (A,B) and preeclamptic pregnancies without (C,D) or with (E,F) fetal growth
restriction (FGR). The expression levels were assessed in trophoblast containing areas with (CK7 + CD45) or without (CK7 – CD45) presence of leukocytes. **P <
0.01. A.U. indicates arbitrary units.
maternal-fetal interface. Growing evidence supports the clinical
benefits and anti-inflammatory effects of drugs targeting the
NLRP3 inflammasome and IL-1β pathway in several diseases
(61), but whether they are pregnancy-safe and effective in
preeclampsia needs to be determined.
This study identified cholesterol crystal mediated NLRP3
inflammasome response as an inflammatory mechanism
associated with maternal-fetal interaction in the uterine wall
decidua in pregnancy. Cholesterol crystals were detected
in considerable amounts in decidua and the expression of
the NLRP3 inflammatory pathway showed importance for
close interaction between fetal trophoblasts and maternal
leukocytes. The increased NLRP3 inflammasome expression in
preeclampsia with normal fetal growth suggests that an enhanced
pro-inflammatory profile in the decidua negatively affects
maternal-fetal communication and plays a role at late stages
of preeclampsia pathology, possibly by intercommunication
with the maternal systemic inflammatory response. The
identification of decidual cholesterol crystals and increased
decidual NLRP3 inflammasome expression in preeclampsia with
normal fetal growth further substantiates the pathophysiological
link between preeclampsia and CVD. This study showed that
combined investigation of cell specific pathological mechanisms
at the two sites of maternal-fetal interface may provide more
comprehensive knowledge of the regulation and importance of
maternal-fetal communication.
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